These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9134531)

  • 21. Huntington's disease gene: regional and cellular expression in brain of normal and affected individuals.
    Landwehrmeyer GB; McNeil SM; Dure LS; Ge P; Aizawa H; Huang Q; Ambrose CM; Duyao MP; Bird ED; Bonilla E
    Ann Neurol; 1995 Feb; 37(2):218-30. PubMed ID: 7847863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress towards a vaccine for Huntington's disease.
    Luthi-Carter R
    Mol Ther; 2003 May; 7(5 Pt 1):569-70. PubMed ID: 12718897
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy.
    Heiser V; Scherzinger E; Boeddrich A; Nordhoff E; Lurz R; Schugardt N; Lehrach H; Wanker EE
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6739-44. PubMed ID: 10829068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concise Review: The Use of Stem Cells for Understanding and Treating Huntington's Disease.
    Connor B
    Stem Cells; 2018 Feb; 36(2):146-160. PubMed ID: 29178352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperhomocysteinaemia in treated patients with Huntington's disease homocysteine in HD.
    Andrich J; Saft C; Arz A; Schneider B; Agelink MW; Kraus PH; Kuhn W; Müller T
    Mov Disord; 2004 Feb; 19(2):226-8. PubMed ID: 14978683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA vaccination against mutant huntingtin ameliorates the HDR6/2 diabetic phenotype.
    Miller TW; Shirley TL; Wolfgang WJ; Kang X; Messer A
    Mol Ther; 2003 May; 7(5 Pt 1):572-9. PubMed ID: 12718899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Huntington's Disease: New Frontiers in Therapeutics.
    Pan L; Feigin A
    Curr Neurol Neurosci Rep; 2021 Feb; 21(3):10. PubMed ID: 33586075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Huntington's disease: progress toward effective disease-modifying treatments and a cure.
    Johnson CD; Davidson BL
    Hum Mol Genet; 2010 Apr; 19(R1):R98-R102. PubMed ID: 20421366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Huntingtin holiday": progress toward an antisense therapy for Huntington's disease.
    Lu XH; Yang XW
    Neuron; 2012 Jun; 74(6):964-6. PubMed ID: 22726826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Huntington's disease: silencing a brutal killer.
    Pfister EL; Zamore PD
    Exp Neurol; 2009 Dec; 220(2):226-9. PubMed ID: 19786020
    [No Abstract]   [Full Text] [Related]  

  • 31. The many faces of autophagy dysfunction in Huntington's disease: from mechanism to therapy.
    Cortes CJ; La Spada AR
    Drug Discov Today; 2014 Jul; 19(7):963-71. PubMed ID: 24632005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stem Cells for Huntington's Disease (SC4HD): An International Consortium to Facilitate Stem Cell-Based Therapy for Huntington's Disease.
    SC4HD Consortium
    J Huntingtons Dis; 2021; 10(2):221-226. PubMed ID: 33814456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective possibilities for Huntington's disease.
    Emerich DF
    Expert Opin Biol Ther; 2001 May; 1(3):467-79. PubMed ID: 11727519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neural expression of the Huntington's disease gene as a chordate evolutionary novelty.
    Kauffman JS; Zinovyeva A; Yagi K; Makabe KW; Raff RA
    J Exp Zool B Mol Dev Evol; 2003 Jun; 297(1):57-64. PubMed ID: 12955844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmaceutical, cellular and genetic therapies for Huntington's disease.
    Handley OJ; Naji JJ; Dunnett SB; Rosser AE
    Clin Sci (Lond); 2006 Jan; 110(1):73-88. PubMed ID: 16336206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Huntington's disease: animal models and transplantation repair.
    Dunnett SB; Svendsen CN
    Curr Opin Neurobiol; 1993 Oct; 3(5):790-6. PubMed ID: 8260831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Untangling huntingtin's mysteries.
    Nat Med; 2000 Oct; 6(10):1063. PubMed ID: 11017110
    [No Abstract]   [Full Text] [Related]  

  • 38. Potential trade-offs in treatment of premanifest Huntington's disease.
    Albin RL; Burke JF
    Mov Disord; 2015 Sep; 30(10):1319-23. PubMed ID: 26173644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain stimulation in Huntington's disease.
    Hartmann CJ; Groiss SJ; Vesper J; Schnitzler A; Wojtecki L
    Neurodegener Dis Manag; 2016 Jun; 6(3):223-36. PubMed ID: 27230813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Misfolded proteins in Huntington disease fetal grafts: further evidence of cell-to-cell transfer?
    Kordower JH; Halliday G
    Ann Neurol; 2014 Jul; 76(1):20-1. PubMed ID: 24961209
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.